Phospholipid profiles of invasive human breast cancer cells are altered towards a less invasive phospholipid profile by the anti-inflammatory agent indomethacin.
Natarajan
K
K
Oncology Section, Division of MR Research, Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Mori
N
N
Artemov
D
D
Aboagye
E O
EO
Chacko
V P
VP
Bhujwalla
Z M
ZM
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology; D002461:Cell Line, Transformed; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology*; D009682:Magnetic Resonance Spectroscopy; D009361:Neoplasm Invasiveness; D010743:Phospholipids / Q000378:metabolism*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010743:Phospholipids; D007213:Indomethacin